Literature DB >> 22223546

Screening for CGG repeat expansion in the FMR1 gene by melting curve analysis of combined 5' and 3' direct triplet-primed PCRs.

Clara R L Teo1, Hai-Yang Law, Caroline G Lee, Samuel S Chong.   

Abstract

BACKGROUND: CGG repeat expansions in the FMR1 (fragile X mental retardation 1) gene are associated with fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency. We evaluated the use of melting curve analysis (MCA) of triplet-primed PCR (TP-PCR) assays as a rapid screening tool for the positive identification of expanded FMR1 alleles in men and women.
METHODS: Both 5'- and 3'-weighted direct TP-PCRs (dTP-PCRs) were evaluated on 29 cell line-derived DNA samples and 44 blinded clinical samples. The presence of expansions was identified by the melting curve profiles generated automatically through MCA on the LightCycler 480 Real-Time PCR System. All samples were also analyzed by capillary electrophoresis to confirm the identities of the PCR fragments that gave rise to the observed melt peak profiles.
RESULTS: The presence of expanded alleles in samples from both males and females produced melt peak profiles that were distinct from those of individuals with the normal allelic form. In the blinded test, positive and negative calls for the presence of an expanded allele corroborated with previously determined genotype classifications for all samples.
CONCLUSIONS: The approach of dTP-PCR plus MCA offers a single-step strategy with high diagnostic sensitivity and specificity for rapid screening detection of FMR1 CGG repeat expansions, regardless of sex. The combined use of 5'- and 3'-weighted dTP-PCR assays minimizes the incidence of false-negative results arising from repeat-flanking deletions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223546     DOI: 10.1373/clinchem.2011.174615

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

Review 1.  Assessing the Fragile X Syndrome Newborn Screening Landscape.

Authors:  Catharine Riley; Anne Wheeler
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

2.  Fragile X Syndrome: Scientific Background and Screening Technologies.

Authors:  Justine I Lyons; Gregory R Kerr; Patricia W Mueller
Journal:  J Mol Diagn       Date:  2015-07-07       Impact factor: 5.568

3.  High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysis.

Authors:  Russell J Butterfield; Carina Imburgia; Katie Mayne; Tara Newcomb; Diane M Dunn; Brett Duval; Marcia L Feldkamp; Nicholas E Johnson; Robert B Weiss
Journal:  Mol Genet Genomic Med       Date:  2021-02-24       Impact factor: 2.183

Review 4.  Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.

Authors:  Indhu-Shree Rajan-Babu; Hai-Yang Law; Chui-Sheun Yoon; Caroline G Lee; Samuel S Chong
Journal:  Expert Rev Mol Med       Date:  2015-05-04       Impact factor: 5.600

5.  Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka.

Authors:  C H W M R Bhagya Chandrasekara; W S Sulochana Wijesundera; Hemamali N Perera; Samuel S Chong; Indhu-Shree Rajan-Babu
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

6.  Validation of a commercially available test that enables the quantification of the numbers of CGG trinucleotide repeat expansion in FMR1 gene.

Authors:  Grace X Y Lim; Minli Yeo; Yvonne Y Koh; Tri Indah Winarni; Indhu-Shree Rajan-Babu; Samuel S Chong; Sultana M H Faradz; Ming Guan
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

7.  A Single Common Assay for Robust and Rapid Fragile X Mental Retardation Syndrome Screening From Dried Blood Spots.

Authors:  Vivienne J Tan; Mulias Lian; Sultana M H Faradz; Tri I Winarni; Samuel S Chong
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

8.  EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders.

Authors:  Valérie Biancalana; Dieter Glaeser; Shirley McQuaid; Peter Steinbach
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 9.  Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders.

Authors:  Indhu-Shree Rajan-Babu; Samuel S Chong
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

Review 10.  FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.

Authors:  Indhu-Shree Rajan-Babu; Mulias Lian; Felicia S H Cheah; Min Chen; Arnold S C Tan; Ethiraj B Prasath; Seong Feei Loh; Samuel S Chong
Journal:  Expert Rev Mol Med       Date:  2017-07-19       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.